EUVIMEDEUVIMED entdecken
Open Access

Hepatic LGALS4 Alleviates Diet‐Induced Steatosis by Promoting AMPK ‐Dependent Fatty Acid Oxidation

Die Hu iD, Jingchi Li, Hailong Cui, Xiaofu Zhang, Sihang Fang, Wen Wen, Xiaoying Li, Qiuyu Wang

Diabetes, Obesity and Metabolism · 2026-09 · 28 (9) · 7875-7891

DOI: 10.1111/dom.70989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 10.06.2026. Verfasst von Die Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan Univ…. Hauptthemen laut MEDLINE: Fatty Acids, AMP-Activated Protein Kinases, Liver, Fatty Liver. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is characterised by impaired hepatic lipid handling, and despite recent therapeutic advances, additional mechanistically distinct therapeutic strategies remain needed. We sought to identify endogenous hepatic regulators induced by energetic challenge that could be leveraged to counteract pathological lipid accumulation. Materials and Methods Integrative transcriptomic analyses were performed across multiple physiological energetic challenges, including cold exposure, β3‐adrenergic activation, fasting and exercise, to identify conserved hepatic energy‐responsive genes. The functional role of Galectin‐4 (LGALS4) was investigated using hepatocyte‐specific gain‐ and loss‐of‐function approaches in high‐fat diet (HFD)‐fed mice and primary hepatocytes. Mitochondrial function was assessed via Seahorse metabolic flux analysis.

Results

LGALS4 emerged as a conserved hepatic factor induced by energetic challenge but suppressed during chronic nutrient excess and in human MASLD liver samples. Hepatocyte‐specific overexpression of Lgals4 markedly attenuated HFD‐induced hepatic steatosis and reduced hepatic triglyceride accumulation, with limited effects on systemic glucose tolerance or insulin sensitivity. Conversely, Lgals4 knockdown exacerbated lipid accumulation and impaired fatty acid oxidation (FAO) gene expression in hepatocytes. Mechanistically, LGALS4 increased AMPK and ACC phosphorylation and upregulated the PGC1α–PPARα fatty acid oxidation programme, leading to enhanced mitochondrial oxidative capacity and reduced lipid accumulation in hepatocytes. These effects were largely abolished by AMPK inhibition, supporting an AMPK‐dependent mechanism.

Conclusions

LGALS4 is an energy‐responsive hepatic regulator that protects against steatosis by promoting AMPK‐dependent fatty acid oxidation. These findings identify LGALS4 as a potential metabolically selective target for MASLD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsAMP-Activated Protein KinasesLiverFatty LiverNon-alcoholic Fatty Liver DiseaseAnimalsDiet, High-FatOxidation-ReductionMiceMaleHumansHepatocytesMice, Inbred C57BLLipid Metabolism

Stichwörter der Autor:innen

AMPKLGALS4MASLDPGC1αfatty acid oxidationhepatic steatosis

Substanzen

Fatty AcidsAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Die Hu

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Hu, D., Li, J., Cui, H., Zhang, X., Fang, S., Wen, W., Li, X., & Wang, Q. (2026). Hepatic LGALS4 Alleviates Diet‐Induced Steatosis by Promoting AMPK ‐Dependent Fatty Acid Oxidation. Diabetes, Obesity and Metabolism, 28(9), 7875-7891. https://doi.org/10.1111/dom.70989

Vancouver

Hu D, Li J, Cui H, Zhang X, Fang S, Wen W, et al. Hepatic LGALS4 Alleviates Diet‐Induced Steatosis by Promoting AMPK ‐Dependent Fatty Acid Oxidation. Diabetes, Obesity and Metabolism. 2026;28(9):7875-7891. doi:10.1111/dom.70989

BibTeX
@article{Hu2026,
  author = {Hu, Die and Li, Jingchi and Cui, Hailong and Zhang, Xiaofu and Fang, Sihang and Wen, Wen and Li, Xiaoying and Wang, Qiuyu},
  title = {Hepatic LGALS4 Alleviates Diet‐Induced Steatosis by Promoting AMPK ‐Dependent Fatty Acid Oxidation},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {9},
  pages = {7875--7891},
  doi = {10.1111/dom.70989}
}
Kostenlos starten →